MedTrace Logo

Evaluating the Effects of Folic Acid Supplementation in Older Adults: The Folic Acid Supplementation Trial (The FAST Study)

NCT00807807 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 133

Last updated 2016-07-29

No results posted yet for this study

Summary

High levels of homocysteine, which is an amino acid in the blood, have been linked to an increased risk of heart disease. This study will examine the effect that differing levels of folic acid have on reducing homocysteine levels among older adults.

Conditions

  • Heart Diseases

Interventions

DIETARY_SUPPLEMENT

Folic Acid

100 mcg, 400 mcg, 1000 mcg, or 2000 mcg of folic acid once a day for 6 weeks

DRUG

Placebo Folic Acid

Placebo folic acid once a day for 6 weeks

Sponsors & Collaborators

  • Johns Hopkins University

    collaborator OTHER

  • National Center for Research Resources (NCRR)

    collaborator NIH

  • National Heart, Lung, and Blood Institute (NHLBI)

    lead NIH

Principal Investigators

  • Lawrence J. Appel, MD, MPH · Johns Hopkins University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1996-06-30
Primary Completion
1996-09-30
Completion
1996-09-30

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00807807 on ClinicalTrials.gov